Your browser doesn't support javascript.
loading
DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis.
Liu, Kevin X; Shang, Helen H; Cacciotti, Chantel; Everdell, Emily; Aizer, Ayal A; Rahman, Rifaquat; Malinowski, Seth; Meredith, David M; Kamihara, Junne; Wen, Patrick Y; Ligon, Keith L; Chi, Susan N; Marcus, Karen J; Yeo, Kee Kiat; Alexandrescu, Sanda; Haas-Kogan, Daphne A.
Affiliation
  • Liu KX; Department of Radiation Oncology, Harvard Medical School, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, 450 Brookline Avenue D1622, Boston, MA, 02215-5418, USA.
  • Shang HH; Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Cacciotti C; Dana Farber/Boston Children's Cancer and Blood Disorder Center, Boston, MA, USA.
  • Everdell E; Division of Pediatric Hematology/Oncology, Western University, London, ON, Canada.
  • Aizer AA; Albany Medical College, Albany, NY, USA.
  • Rahman R; Department of Radiation Oncology, Harvard Medical School, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, 450 Brookline Avenue D1622, Boston, MA, 02215-5418, USA.
  • Malinowski S; Department of Radiation Oncology, Harvard Medical School, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, 450 Brookline Avenue D1622, Boston, MA, 02215-5418, USA.
  • Meredith DM; Department of Oncologic Pathology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kamihara J; Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
  • Wen PY; Dana Farber/Boston Children's Cancer and Blood Disorder Center, Boston, MA, USA.
  • Ligon KL; Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Chi SN; Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
  • Marcus KJ; Dana Farber/Boston Children's Cancer and Blood Disorder Center, Boston, MA, USA.
  • Yeo KK; Department of Radiation Oncology, Harvard Medical School, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, 450 Brookline Avenue D1622, Boston, MA, 02215-5418, USA.
  • Alexandrescu S; Dana Farber/Boston Children's Cancer and Blood Disorder Center, Boston, MA, USA.
  • Haas-Kogan DA; Department of Pathology, Harvard Medical School Boston, Boston Children's Hospital, 300 Longwood Ave, Bader 104, Boston, MA, 02115, USA. Sanda.Alexandrescu@childrens.harvard.edu.
J Neurooncol ; 157(3): 499-510, 2022 May.
Article in En | MEDLINE | ID: mdl-35384518
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Central Nervous System Neoplasms / Glioma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Child / Humans Language: En Journal: J Neurooncol Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Central Nervous System Neoplasms / Glioma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Child / Humans Language: En Journal: J Neurooncol Year: 2022 Type: Article Affiliation country: United States